Noxopharm Limited (NOX.AX)
Develops cancer treatments and mRNA vaccines using two technology platforms
0.09-0.08%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-23.3%
The outlook
NOX.AX trades at $0.092, positioned well above both its 50- and 200-day moving averages, signaling upward momentum in its intermediate trend. The stock sits roughly midway in its 52-week range, with analyst sentiment leaning bullish overall. Current market data shows the price holding steady with no dramatic intraday movement.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range49% of the way from its 52-week low to high
Market cap
$28.3M
52-wk high
0.14
52-wk low
0.05
50-day avg
0.08
200-day avg
0.08
Trailing P/E
—